跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMBELVIST SOLUTION FOR INJECTION IN PREFILLED SYRINGE 0.1MMOL/ML - HSA Drug Approval Details
Approvals
/
HSA
/
AMBELVIST SOLUTION FOR INJECTION IN PREFILLED SYRINGE 0.1MMOL/ML
Approved
THERAPEUTIC
AMBELVIST SOLUTION FOR INJECTION IN PREFILLED SYRINGE 0.1MMOL/ML
Bayer AG (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Sep 4, 2026
Approval ID
7a23b58b56470ae5
Company
Bayer AG (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
7a23b58b56470ae5
Drug Name
AMBELVIST SOLUTION FOR INJECTION IN PREFILLED SYRINGE 0.1MMOL/ML
Product Name
AMBELVIST SOLUTION FOR INJECTION IN PREFILLED SYRINGE 0.1MMOL/ML
Approval Number
SIN17632P
Approval Date
2026-09-04
Registrant
BAYER (SOUTH EAST ASIA) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 4, 2026
Approval ID
7a23b58b56470ae5
Type
Therapeutic
Back to HSA Approvals
